Although Kleinberge et al. showed that sTREM2 levels were reduced in the CSF of AD patients [56], other studies have shown that sTREM2 levels in the CSF increased with age and were positively correlated with the levels of Aβ42 and tau protein [26, 57–59]. This evidence concerns the gene MAPT and Alzheimer disease.